Rylaze 10 MG/0.5 ML vial 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FE0TK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,452
Award facts
- Contract value 100% obligated
- $51,451.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $51,451.74 delivery order to AmerisourceBergen Drug Corp for RYLAZE 10 mg/0.5 mL vials on October 17, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RYLAZE (asparaginase) is a critical pharmaceutical used in cancer treatment protocols, particularly for acute lymphoblastic leukemia, making this delivery essential to military and federal healthcare operations.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated consistent capability to meet competitive federal procurement requirements across multiple therapeutic domains and customer groups, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB26FE0TK?
SPE2DB26FE0TK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FE0TK worth?
The government has obligated $51,452 on SPE2DB26FE0TK.
Is contract SPE2DB26FE0TK an order under another contract?
Yes. SPE2DB26FE0TK is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB26FE0TK competed?
The extent of competition for SPE2DB26FE0TK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award